Yes, the DMD Research Panel v1.0 supports mixed usage with the NEXome-series
Panels. The CDS (coding sequence) probes of the DMD Research Panel v1.0 can be
separated to avoid overlap with the DMD gene exon probes in the whole-exome
panel, thereby eliminating data redundancy.
Fusion
genes serve as critical molecular markers for the diagnosis and treatment of
hematologic malignancies, making their accurate detection essential. The DNA
workflow detects gene fusions by designing probes covering intronic regions;
however, due to the large size and high repetitiveness of introns, relying
solely on DNA detection poses challenges such as high cost and incomplete
coverage, and it cannot confirm the functional impact of fusion events. In
contrast, the RNA workflow directly focuses on the transcript level, enabling
precise identification of actual fusion events and their partner genes while
assessing whether these fusions lead to aberrant transcription. Consequently,
the combined use of DNA and RNA workflows provides a “dual safeguard” for fusion gene detection, enhancing both the
comprehensiveness and accuracy of the results.
Total
RNA-seq requires rRNA depletion and individual reactions per sample, increasing
both complexity and cost. Moreover, total RNA-seq exhibits relatively lower
sensitivity, particularly in detecting low-frequency fusion events in
low-expression samples. In contrast, the DNA panel in NanoHema Panel v2.0
already covers the intronic regions of key genes, allowing users to flexibly
add custom intronic regions based on requirements and budget without the need
for a separate RNA panel.
NanoHema Panel v2.0 is a comprehensive large panel that covers a wide range of hematologic malignancy-associated gene variants. To meet diverse clinical needs, the panel offers multiple customization options:
• It can be flexibly split into multiple sub-panels (e.g., for acute myeloid leukemia [AML], lymphoblastic leukemia, T-cell lymphoma, and B-cell lymphoma).
• Additional target genes can be incorporated based on specific research or diagnostic requirements, enabling the creation of a personalized detection solution.